Erik Ekman
Directeur/Membre du Conseil chez ICONOVO AB
Profil
Erik Ekman is currently the Chief Executive Officer at Bluefish Pharmaceuticals AB since 2017 and the Director at Iconovo AB since 2024.
He graduated from the University of Linköping.
Postes actifs de Erik Ekman
| Sociétés | Poste | Début |
|---|---|---|
| ICONOVO AB | Directeur/Membre du Conseil | 01/01/2024 |
Bluefish Pharmaceuticals AB
 Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Bluefish Pharmaceuticals AB manufactures generic pharmaceutical products. Its therapeutic areas include analgesic, antibiotics, antifungal, antiviral, cardiovascular, endocrinology, diabetes, gastrointestinal, genito-urinary, inflammatory, oncology, and respiratory. The company was founded by Karl Alexius Tiger Karlsson in 2005 and is headquartered in Stockholm, Sweden. | Directeur Général | 01/11/2017 |
Formation de Erik Ekman
| University of Linköping | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ICONOVO AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Bluefish Pharmaceuticals AB manufactures generic pharmaceutical products. Its therapeutic areas include analgesic, antibiotics, antifungal, antiviral, cardiovascular, endocrinology, diabetes, gastrointestinal, genito-urinary, inflammatory, oncology, and respiratory. The company was founded by Karl Alexius Tiger Karlsson in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
